2023-06-02
3-20297
MJ Biotech, Inc.
/litigation/apdocuments/ap-3-20297.xml
2021-05-11
34-91850
Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934
/litigation/admin/2021/34-91850.pdf
2021-06-16
34-92191
Order to Show Cause
/litigation/opinions/2021/34-92191.pdf
2021-09-03
34-92880
Opinion of the Commission
/litigation/opinions/2021/34-92880.pdf
2022-01-28
Respondent Notice of Motion to Set Aside Default with Exhibits 1-3
/litigation/apdocuments/3-20297-2022-01-28-respondent-notice.pdf
2022-02-04
Division Response in Opposition to Respondent Motion to Set Aside Default with Exhibits 1 and 2
/litigation/apdocuments/3-20297-2022-02-04-division-response.pdf
2022-02-28
Respondent's Reply to Division's Opposition to Petitioner's Motion to Set Aside Default
/litigation/apdocuments/3-20297-2022-02-28-respondents-reply.pdf
2021-06-02
Division of Enforcement’s Service Declaration
/litigation/apdocuments/3-20297-2021-06-02-declaration-of-sandhya-harris.pdf
2022-02-07
Division of Enforcement’s Updated Certificate of Service
/litigation/apdocuments/3-20297-2022-02-07-updated-service-certificate.pdf
2023-06-02
34-97644
Order Granting Motion to Set Aside Default and Ordering Briefs
/litigation/opinions/2023/34-97644.pdf
2023-06-30
Joint Mem. Re June 2, 2023 Order
/litigation/apdocuments/3-20297-2023-06-30-divi-resp-joint-memor.pdf